Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma ; volume:14 ; number:11 ; day:16 ; month:11 ; year:2023 ; pages:1-17 ; date:11.2023
Cell death & disease ; 14, Heft 11 (16.11.2023), 1-17, 11.2023
- Urheber
-
Borankova, Karolina
Krchniakova, Maria
Leck, Lionel Y. W.
Kubistova, Adela
Neradil, Jakub
Jansson, Patric J.
Hogarty, Michael D.
Skoda, Jan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-023-06278-x
- URN
-
urn:nbn:de:101:1-2024013121033959185499
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Borankova, Karolina
- Krchniakova, Maria
- Leck, Lionel Y. W.
- Kubistova, Adela
- Neradil, Jakub
- Jansson, Patric J.
- Hogarty, Michael D.
- Skoda, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers
Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance
Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
Modulation of multidrug resistance proteins by statins in human neuroblastoma
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression
A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells
Modeling synthetic lethality
Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Author Correction: Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
Poetry overcomes boundaries
Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers
Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance
Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
Modulation of multidrug resistance proteins by statins in human neuroblastoma
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression
A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells
Modeling synthetic lethality
Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Author Correction: Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
Poetry overcomes boundaries
Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers
Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance
Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
Modulation of multidrug resistance proteins by statins in human neuroblastoma
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression
A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells
Modeling synthetic lethality
Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
Author Correction: Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance